The ART management team has combined business and pharmaceutical industry experience of over forty years, with extensive experience in drug delivery, formulation, product development, marketing and business and commercial development.
Howard Edelman, CEO
Howard Edelman is a medical device executive accomplished in all phases of medical product development and operations in a variety of organizational structures. Most recently, Mr. Edelman was General Manager of Cothera, a division of United Orthopedic Group, a global orthopedic company which provides medical devices and patient services into the secondary orthopedic market. Cothera was recently purchased by Breg in November of 2014. Mr. Edelman advises a variety of medical device and biotech companies and is an Expert Advisor with the California Life Sciences Association (BayBio), a mentor at the UCSF Lean Launchpad, and a coach at the Alchemist Accelerator. He is also a member of Life Science Angels, the premier angel investment group investing in medical devices, diagnostics, pharmaceuticals, biotechnology, and digital health.
Previously, Howard Edelman was the Founder and CEO of VitalWear, a leader in thermal and compression therapy. In 2009, VitalWear was named on the INC 500 list of fastest growing private companies and on the San Francisco Business Times Fast 100. In 2010, Medical Device & Diagnostic Industry listed VitalWear as one of the top 50 medical device companies to watch. Mr. Edelman has served in management roles in firms such as Johnson & Johnson, Zeiss, CooperVision, and Bio-Rad Laboratories and various startup companies in the Bay Area. Mr. Edelman sat on the Research Committee for the Juvenile Diabetes Research Foundation. Mr. Edelman holds a B.S. in Biomedical Engineering from Boston University.
Alex Battaglia, M.D., Ph.D, Chief Science Officer
Alex Battaglia, M.D., Ph.D, works as the Chief Science Officer of Advanced Resin Therapeutics and is the primary inventor of the technology. Advanced Resin Technology is the art and science of combining particular natural resins with specific medications to make them safely act more quickly and for a longer period of time. Dr. Battaglia has elucidated ART’s mechanism of action by determining the way in which these resins potentate medications on a molecular level. He manages all scientific affairs including formulation development, Agilent HPLC protocol operations, in vitro diffusion cell and toxicity experiments, and in vivo protocols. He also manages lab personnel. He interacts with numerous independent labs, and is actively involved in writing and managing the Company’s intellectual property portfolio which includes 28 patents. Dr. Battaglia is also an Otologist, Neurotologist, Head and Neck Surgeon and a Principal Investigator for Kaiser Permanente and a volunteer Assistant Clinical Professor for the Department of Surgery at the University of California, San Diego. He has had extensive medical surgical training and undertaken a wide range of research in clinical Otology and Neurotology and Molecular Biology. His accolades include being a Researcher at the National Institutes of Health, California Institute of Technology, and Columbia University, and he has authored over 20 abstracts, articles and chapters during the course of his academic and medical career. Dr. Battaglia has an M.D. from Columbia University and a Ph.D. in Molecular Pathology from University of California, San Diego.
Tracey Forster, CMO
Tracey Forster is a 20-year General Management and classically trained Marketing veteran with a track record of high growth by creating innovative strategies for consumer packaged goods, luxury and B2B SaaS companies. Throughout her career, she has worked with brands, both big and small, focusing on marketing, growth and go-to-market strategy. Her most recent accomplishment was turning around Sir Richard’s Condom Company. In under a year, she drove sales for the business, increased brand awareness and attracted a private equity firm whom she and the Board eventually sold the company to.
Prior to Sir Richard’s, Tracey was CMO for DPSI, a cloud-based SaaS company (which also had a successful exit in 2014) and held various marketing roles with GlaxoSmithKline, Johnson & Johnson and Estee Lauder. Additionally, she began her career with NY-based ad agencies DDB Needham and Saatchi & Saatchi. Tracey was responsible for creating the “Stick It To Your Snorer” promotion for GlaxoSmithKline’s Breathe Right Nose Strips that won the Silver SABRE Award for “Superior Achievement in Branding and Recognition.” Tracey currently resides in the Bay area with her family and holds a B.S. in Marketing from the University of Florida.